Impact of COVID-19 in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis.
Transpl Infect Dis
; 24(2): e13792, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1626964
ABSTRACT
BACKGROUND:
Hematopoietic stem cell transplant (HSCT) recipients are at increased risk of mortality and morbidity with coronavirus disease 2019 (COVID-19) due to severe immune dysfunction.METHODS:
A literature search was performed on PubMed, Cochrane, and Clinical trials.gov from the date of inception to 12/08/2021. We identified 19 original studies reporting data on COVID-19 in HSCT recipients after screening 292 articles. Data were extracted following preferred reporting items for systematic reviews and meta-analysis guidelines. Quality evaluation was done using the National Institutes of Health (NIH) quality assessment tool. Inter-study variance was calculated using Der Simonian-Laird Estimator. Pooled analysis was conducted using MetaXL. A random-effects model was used to estimate the proportions with 95% confidence intervals (CI).RESULTS:
Of 6711 patients in 19 studies, 2031 HSCT patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection were analyzed. The median age of patients was 56.9 (range 1-81.6) years, and 63% patients were men according to 14 studies. The median time from transplant to SARS-CoV-2 infection for autologous (auto) and allogeneic (allo) HSCT patients was 23.2 (0.33-350.5) months and 16.4 (0.2-292.7) months, respectively. The median follow-up time after COVID-19 diagnosis was 28 (0-262) days. The COVID-19 mortality rate was 19% (95% CI 0.15-0.24, I2 = 76%, n = 373/2031). The pooled mortality rate was 17% (95% CI 0.12-0.24, I2 = 78%, n = 147/904) in auto-HSCT patients and 21% (95% CI 0.16-0.25, I2 = 60%, n = 231/1103) in allo-HSCT patients.CONCLUSIONS:
HSCT recipients have a high risk of mortality and clinical complications due to COVID-19. There is a need for ongoing vigilance, masks, and social distancing, vaccination, and aggressive management of SARS-CoV-2 infection in HSCT recipients.Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Trasplante de Células Madre Hematopoyéticas
/
COVID-19
Tipo de estudio:
Estudio de cohorte
/
Estudios diagnósticos
/
Estudio experimental
/
Estudio observacional
/
Estudio pronóstico
/
Ensayo controlado aleatorizado
/
Revisiones
/
Revisión sistemática/Meta análisis
Tópicos:
Vacunas
Límite:
Adolescente
/
Adulto
/
Anciano
/
Niño
/
Child, preschool
/
Humanos
/
Lactante
/
Masculino
/
Middle aged
/
Young_adult
Idioma:
Inglés
Revista:
Transpl Infect Dis
Asunto de la revista:
Trasplante
Año:
2022
Tipo del documento:
Artículo
País de afiliación:
Tid.13792
Similares
MEDLINE
...
LILACS
LIS